Short-course Fluoroquinolones in Acute Exacerbations of Chronic Bronchitis

Mark H Gotfried; Ronald F Grossman

Disclosures

Expert Rev Resp Med. 2010;4(5):661-672. 

In This Article

Conclusion

A 5-day, short-course fluoroquinolone regimen is at least as effective in clinical resolution and bacteriological cure for patients with AECB as compared with standard therapy. In addition, data suggest that 5-day fluoroquinolone therapy offers beneficial characteristics for the management of AECB, including faster resolution of symptoms, faster rate of recovery, fewer relapses, shorter and fewer hospitalization stays, and prolonged duration between recurrences.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....